Clinical Trial Update: Low Molecular Weight Heparin to Improve Pregnancy Outcome in Patients With Recurrent Implantation Failure [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating low molecular weight heparin to improve pregnancy outcomes in patients with recurrent implantation failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sterility

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Sterility | Phase 4 | Status: COMPLETED